2021
DOI: 10.7171/jbt.21-3203-005
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Saliva-Optimized RT-LAMP Assay for SARS-CoV-2

Abstract: Conventional reverse transcription quantitative polymerase chain reaction (RT-qPCR) technology has struggled to fulfill the unprecedented need for diagnostic testing created by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Complexity and cost hinder access to testing, and long turnaround time decreases its utility. To ameliorate these issues, we focus on saliva and introduce several advances to colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) tech… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…Our internal target was to achieve an analytical LoD (95% detection rate) for synthetic RNA targets of ≤15 copies/reaction. Our desired level of sensitivity would allow the assay to completely bypass any type of laborious RNA extraction/concentration and still be able to detect low viral titers 69 , 70 (<50 viral RNA copies/µl sample) in clinical specimens even with modest sample input volumes (~10% of reaction volume). In search of additional sensitivity, some groups have attempted to implement crude purification and concentration protocols, for example by using silica mesh/gel 55 , carboxylated nucleic acid capture beads, or dramatically increasing the reaction volume along with reagent usage and cost 71 .…”
Section: Resultsmentioning
confidence: 99%
“…Our internal target was to achieve an analytical LoD (95% detection rate) for synthetic RNA targets of ≤15 copies/reaction. Our desired level of sensitivity would allow the assay to completely bypass any type of laborious RNA extraction/concentration and still be able to detect low viral titers 69 , 70 (<50 viral RNA copies/µl sample) in clinical specimens even with modest sample input volumes (~10% of reaction volume). In search of additional sensitivity, some groups have attempted to implement crude purification and concentration protocols, for example by using silica mesh/gel 55 , carboxylated nucleic acid capture beads, or dramatically increasing the reaction volume along with reagent usage and cost 71 .…”
Section: Resultsmentioning
confidence: 99%
“…First, the specificity of these six sets of LAMP primers had been well studied in the previous studies reported by the different laboratories ( Broughton et al, 2020 ; Dong et al, 2021 ; Jamwal et al, 2021 ; Jiang et al, 2020 ; Nawattanapaiboon et al, 2021 ; Park et al, 2020 ; Yu et al, 2021 ; Zhang & Tanner, 2021 ). Second, the sequence of the LAMP primers was compared to aligned sequences of some other coronaviruses (including MERS-CoV, SARS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63, and HCoV-229E), all of which had some nucleotides mismatching with our LAMP primers, supporting the specificity of the developed RT-LAMP assay.…”
Section: Resultsmentioning
confidence: 99%
“…In this study, the LAMP primer sets targeting the ORF1ab, N, and E genes were constructed based on RT-LAMP assays previously reported by the different laboratories, respectively ( Broughton et al, 2020 ; Dong et al, 2021 ; Jamwal et al, 2021 ; Jiang et al, 2020 ; Nawattanapaiboon et al, 2021 ; Park et al, 2020 ; Yu et al, 2021 ; Zhang & Tanner, 2021 ). A set of LAMP primers consisting of six primers (F3, B3, FIP, BIP, LF, LB) targeted eight distinct regions of the templates, and all primers were ordered from Sangon Biotech (Shanghai), LAMP primer mixtures (F3/B3 2 µM each; FIP/BIP 16 µM each; LF/LB 4 µM each) were prepared and used for the further RT-LAMP reactions.…”
Section: Methodsmentioning
confidence: 99%
“…RT-LAMP for COVID-19 diagnosis was also improved using more amenable samples, such as saliva. Rabe and Cepko, 15 and Yu et al 30 used saliva samples with a previous RNA extraction, while Lalli et al 22 and Kobayashi et al 31 reported an assay preserving RNA by the addition of proteinase K or guanidine/DTT to saliva samples, respectively. Several modifications to this test have been discussed.…”
Section: Discussionmentioning
confidence: 99%